[Pubmed] Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases

[RSS-Bot]

Acta Neuropathol. 2024 Jan 12;147(1):15. doi: 10.1007/s00401-023-02669-8.

ABSTRACT

Histopathological analysis stands as the gold standard for the identification and differentiation of inflammatory neuromuscular diseases. These disorders continue to constitute a diagnostic challenge due to their clinical heterogeneity, rarity and overlapping features. To establish standardized protocols for the diagnosis of inflammatory neuromuscular diseases, the development of cost-effective and widely applicable tools is crucial, especially in settings constrained by limited resources. The focus of this review is to emphasize the diagnostic value of major histocompatibility complex (MHC) and complement patterns in the immunohistochemical analysis of these diseases. We explore the immunological background of MHC and complement signatures that characterize inflammatory features, with a specific focus on idiopathic inflammatory myopathies. With this approach, we aim to provide a diagnostic algorithm that may improve and simplify the diagnostic workup based on a limited panel of stainings. Our approach acknowledges the current limitations in the field of inflammatory neuromuscular diseases, particularly the scarcity of large-scale, prospective studies that validate the diagnostic potential of these markers. Further efforts are needed to establish a consensus on the diagnostic protocol to effectively distinguish these diseases.

PMID:38214778 | DOI:10.1007/s00401-023-02669-8


Source: https://pubmed.ncbi.nlm.nih.gov/3821477 ... 6&v=2.18.0